Darren Snellgrove is Vice President, Group Finance, Worldwide Pharmaceuticals. In this position, Darren will provide strategic and financial leadership to the Global Pharmaceuticals Group and partner with the Group Operating Company to further drive above-market growth with transformational medical innovation that yields successful business outcomes for the sector and enterprise.
Most recently, Darren was Vice President, Finance for Janssen Research & Development. Working closely with Pete Batesko, Darren led multiple strategic workstreams, improving financial performance, enhancing efficiency and effectiveness while significantly increasing the value of the portfolio. He was also a key leader for the Janssen COVID-19 vaccine project.
Prior to his current role, Darren was Vice President, Finance and Operations for Johnson & Johnson Innovation. This role included the Innovation Centers located in San Francisco, Boston, London and Shanghai, Johnson & Johnson Innovation – JJDC (J&J’s venture investment arm), J&J’s external incubators Johnson & Johnson Innovation, JLABS, and Janssen Business Development (JBD) which is responsible for Pharmaceutical L&A. Darren helped to develop and build the business strategy for J&J Innovation, where he and his team built an impressive external portfolio using value creating deal structures in areas such as gene therapy, the microbiome, 3D Printing, surgical robotics, immuno-oncology, light therapy, wearables, and in Johnson & Johnson’s core therapeutic/business focus areas.
Darren joined Johnson & Johnson through the acquisition of Centocor in 1999, where he spent a number of years in roles of increasing responsibility supporting a variety of functions, including Commercial, R&D, and Business Development. Beginning in 2002, Darren spent three years in J&J’s Mergers and Acquisitions Finance group, providing financial leadership on over 100 potential acquisitions, major licensing deals, equity investments, options, structures, and divestitures across all sectors. Darren’s continued success led to his appointment in a series of leadership roles, where he quickly developed new capabilities and led to numerous growth opportunities in both Pharmaceuticals and Medical Devices. Prior to joining the Johnson & Johnson Innovation Organization, Darren was VP of Finance and Procurement, Chief Financial Officer at Janssen AI.
Darren holds a Bachelor of Arts in Economics and Philosophy from Southampton University in England and an MBA from Villanova University.